European Leukemia Trial Registry
Trial: ALL GMALL Marqibo

More Details
Title Safety and Efficacy of Marqibo (liposomal vincristine) in Relapsed Acute Lymphoblastic Leukemia
Scientific Title A Phase 2 Study to Evaluate the Safety and Efficacy of Weekly Doses of Marqibo® (vincristine sulfate liposomes injection) in Adult Patients with Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia (ALL) in Second Relapse or Adult Patients with Philadelphia Chromosome-negative ALL Who Failed Two Treatment Lines of Anti-leukemia Chemotherapy
Short Title ALL GMALL Marqibo
Trialgroup GMALL
Type of Trial multicentric, open-label
Disease Acute lymphoblastic leukemia(ALL) All subtypes
Age >= 18 years
Status Closed
Start of Recruitment 01.02.2008
Leader O'Brian, MD, Susan
Centre of Trial University of Texas M. D. Anderson Cancer Center
Shortprotocol Shortprotocol
created 04.03.2008 Roswitha Kotthoff
changed 13.11.2014 Alexandra Lucaciu
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org